Drug Trial Radar · NCT07755410
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
312
Planned (sponsor's estimate)
Start
Aug 10, 2026
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure safety and the improvement in symptoms in subjects with ADHD when taking ALKS 7290 tablets compared with placebo tablets.
Conditions
- Attention Deficit Disorder With Hyperactivity (ADHD)
Interventions
ALKS 7290Drug
ALKS 7290 tablets taken daily, orally, for 4 weeks
PlaceboDrug
Placebo capsule taken daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 4 in Attention Deficit Disorder Investigator Symptom Rating Scale (AISRS) total scoreTime frame: Baseline to Week 4
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Alkermes Investigational Site
Little Rock, Arkansas · Recruiting
Alkermes Investigational Site
Chino, California · Recruiting
Alkermes Investigator Site
Chino, California · Recruiting
Alkermes Investigational Site
Clermont, Florida · Recruiting
Alkermes Investigational Site
Jacksonville, Florida · Recruiting
Alkermes Investigational Site
Lakeland, Florida · Recruiting
Alkermes Investigational Site
Largo, Florida · Recruiting
Alkermes Investigational Site
Maitland, Florida · Recruiting
Alkermes Investigator Site
Maitland, Florida · Recruiting
Alkermes Investigational Site
Maitland, Florida · Recruiting
Alkermes Investigational Site
Orange City, Florida · Recruiting
Alkermes Investigational Site
Orlando, Florida · Recruiting
Alkermes Investigational Site
Tampa, Florida · Recruiting
Alkermes Investigational Site
Decatur, Georgia · Recruiting
Alkermes Investigational Site
Foxborough, Massachusetts · Recruiting
Alkermes Investigational Site
Watertown, Massachusetts · Recruiting
Alkermes Investigational Site
Detroit, Michigan · Recruiting
Alkermes Investigational Site
Lincoln, Nebraska · Recruiting
Alkermes Investigational Site
Las Vegas, Nevada · Recruiting
Alkermes Investigational Site
Las Vegas, Nevada · Recruiting
Alkermes Investigational Site
North Canton, Ohio · Recruiting
Alkermes Investigational Site
East Providence, Rhode Island · Recruiting
Alkermes Investigational Site
North Charleston, South Carolina · Recruiting
Alkermes Investigational Site
Memphis, Tennessee · Recruiting
Alkermes Investigational Site
Austin, Texas · Recruiting
Alkermes Investigational Site
Austin, Texas · Recruiting
Alkermes Investigational Site
The Woodlands, Texas · Recruiting
Alkermes Investigational Site
Bellevue, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.